FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

GlycoMimetics Phase 3 Leukemia Study Fails

GlycoMimetics says its Phase 3 study of uproleselan plus chemotherapy in acute myeloid leukemia patients did not achieve a statistically significant i...

latest-news-card-1
Human Drugs

REMS Logic Model Draft Guidance

FDA posts a draft guidance entitled REMS Logic Model: A Framework to Link Program Design With Assessment" to help applicants with designing and managi...

latest-news-card-1
Federal Register

12 No-Longer-Marketed ANDAs Withdrawn

Federal Register notice: FDA withdraws approval of 12 ANDAs from multiple applicants after they notified the agency that they were no longer marketed.

latest-news-card-1
Federal Register

Test Emergency Policies Under Sec. 564 Guide

Federal Register notice: FDA makes available a draft guidance entitled Consideration of Enforcement Policies for Tests During a Section 564 Declared E...

Medical Devices

FDA Clears ZygoFix Spinal Fusion Alternative

FDA clears a ZygoFix 510(k) for its zLOCK Lumbar Facet Fixation System an implant that adapts to the joint's anatomy during insertion to offer increas...

latest-news-card-1
Medical Devices

Lyric Hearing Aid Cleared for Self Replacement

FDA clears a Phonak 510(k) for its Phonak Lyric hearing aid and a self-replacement option to reduce office visits.

latest-news-card-1
Federal Register

Veterinary Pharmaceutical Development Draft Guide

Federal Register notice: FDA makes available a veterinary-use draft guidance entitled #290 (VICH GL61) Pharmaceutical Development.

latest-news-card-1
FDA General

WSJ Apologizes for Supporting Califf

An unusually strident Wall Street Journal editorial apologizes to its readers for supporting FDA commissioner Robert Califfs appointment now that hes ...

latest-news-card-1
Biologics

Dupixent COPD sBLA May Face Review Delay

Regeneron faces a potential approval delay on its supplemental BLA for Dupixent (dupilumab) as an add-on maintenance treatment in certain adult patien...

latest-news-card-1
FDA General

Bill to Restrict Revolving Door When FDAers Depart

A just-introduced bill, Fixing Administrations Unethical Corrupt Influence Act, restricts top federal health officials at FDA, CDC and NIH from cashin...